![The design and evaluation of hybrid controlled trials that leverage external data and randomization | Nature Communications The design and evaluation of hybrid controlled trials that leverage external data and randomization | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-33192-1/MediaObjects/41467_2022_33192_Fig1_HTML.png)
The design and evaluation of hybrid controlled trials that leverage external data and randomization | Nature Communications
![Frontiers | Application of Real-World Data to External Control Groups in Oncology Clinical Trial Drug Development Frontiers | Application of Real-World Data to External Control Groups in Oncology Clinical Trial Drug Development](https://www.frontiersin.org/files/Articles/695936/fonc-11-695936-HTML-r1/image_m/fonc-11-695936-g001.jpg)
Frontiers | Application of Real-World Data to External Control Groups in Oncology Clinical Trial Drug Development
![A Framework for Methodological Choice and Evidence Assessment for Studies Using External Comparators from Real-World Data | SpringerLink A Framework for Methodological Choice and Evidence Assessment for Studies Using External Comparators from Real-World Data | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40264-020-00944-1/MediaObjects/40264_2020_944_Fig1_HTML.png)
A Framework for Methodological Choice and Evidence Assessment for Studies Using External Comparators from Real-World Data | SpringerLink
![Making a Difference for Cancer Patients with Hybrid and External Control Arms in Clinical Trials - COTA Healthcare Making a Difference for Cancer Patients with Hybrid and External Control Arms in Clinical Trials - COTA Healthcare](https://sp-ao.shortpixel.ai/client/to_webp,q_glossy,ret_img,w_768,h_384/https://cotahealthcare.com/wp-content/uploads/iStock-1202232039-768x384.jpg)
Making a Difference for Cancer Patients with Hybrid and External Control Arms in Clinical Trials - COTA Healthcare
![Hybrid-control arm construction using historical trial data for an early-phase, randomized controlled trial in metastatic colorectal cancer | Communications Medicine Hybrid-control arm construction using historical trial data for an early-phase, randomized controlled trial in metastatic colorectal cancer | Communications Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs43856-022-00155-y/MediaObjects/43856_2022_155_Fig1_HTML.png)
Hybrid-control arm construction using historical trial data for an early-phase, randomized controlled trial in metastatic colorectal cancer | Communications Medicine
![Augmenting control arms with real-world data for cancer trials: Hybrid control arm methods and considerations - ScienceDirect Augmenting control arms with real-world data for cancer trials: Hybrid control arm methods and considerations - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S245186542200117X-gr1.jpg)
Augmenting control arms with real-world data for cancer trials: Hybrid control arm methods and considerations - ScienceDirect
![Roche's External Control Arms Show What Real-World Evidence Can Look Like In Practice | Report Store | Pharma intelligence Roche's External Control Arms Show What Real-World Evidence Can Look Like In Practice | Report Store | Pharma intelligence](https://pharmastore.informa.com/wp-content/uploads/2018/06/JN000-Insights-Article-06-2018-Pink-3-cover.png)
Roche's External Control Arms Show What Real-World Evidence Can Look Like In Practice | Report Store | Pharma intelligence
![On Biostatistics and Clinical Trials: Synthetic Control Arm (SCA), External Control, Historical Control On Biostatistics and Clinical Trials: Synthetic Control Arm (SCA), External Control, Historical Control](https://1.bp.blogspot.com/-kY0h8CQfklU/X-9WuMNGuzI/AAAAAAAADmw/yQmKpW2Rs0MjdFnkYVBgKuwjqLcyxEjMgCLcBGAsYHQ/s641/Screenshot%2B2021-01-01%2B120115.jpg)
On Biostatistics and Clinical Trials: Synthetic Control Arm (SCA), External Control, Historical Control
![Leveraging external data in the design and analysis of clinical trials in neuro-oncology - The Lancet Oncology Leveraging external data in the design and analysis of clinical trials in neuro-oncology - The Lancet Oncology](https://www.thelancet.com/cms/attachment/2706ca6f-a1fc-472a-802f-32ebdd9013c3/gr2_lrg.jpg)